Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
Revenue
Nichi-Iko Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
Revenue
¥179.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's Revenue?
Revenue
179.1B
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Revenue amounts to 179.1B JPY.
What is Nichi-Iko Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Nichi-Iko Pharmaceutical Co Ltd have been 2% over the past three years , 4% over the past five years .